Applied Genetic Technologies Corp (AGTC)

2.80 -0.07  -2.44% NASDAQ Dec 9, 13:22 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/07/2020 08:00 EST Misc Applied Genetic Technologies Corp Second Quarter Earnings Conference Call in 2020
02/07/2020 Earnings Applied Genetic Technologies Corp Second Quarter Earnings in 2020 Release
12/04/2019 14:00 EST Misc Applied Genetic Technologies Corp Annual General Meeting for 2019
11/12/2019 04:30 EST Misc Applied Genetic Technologies Corp First Quarter Earnings Conference Call in 2020
11/12/2019 Earnings Applied Genetic Technologies Corp First Quarter Earnings in 2020 Release
09/26/2019 Earnings Applied Genetic Technologies Corp Fourth Quarter Earnings for 2019 Release
09/26/2019 16:30 EDT Misc Applied Genetic Technologies Corp Fourth Quarter Earnings Conference Call for 2019
09/26/2019 Misc Applied Genetic Technologies Corp Annual Report for 2019
05/07/2019 16:30 EDT Misc Applied Genetic Technologies Corp Third Quarter Earnings Conference Call in 2019
05/07/2019 Earnings Applied Genetic Technologies Corp Third Quarter Earnings in 2019 Release
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.agtc.com
  • Investor Relations URL: http://ir.agtc.com/
  • HQ State/Province: Florida
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Feb. 07, 2020
  • Last Earnings Release: Nov. 12, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Applied Genetic Technologies Corp is a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. Its initial focus is in the field of ophthalmology, where it has active clinical trials in X-linked retinitis pigmentosa, achromatopsia (ACHM CNGB3 & ACHM CNGA3), and X-linked retinoschisis. In addition to its clinical trials, company has preclinical programs in optogenetics, adrenoleukodystrophy, which is a disease of the central nervous system, other ophthalmology and otology indications. The optogenetics program is being developed in collaboration with Bionic Sight.

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.